SK282746B6 - Spôsob prípravy antigénového materiálu obsahujúceho polysacharid a/alebo glykopeptid, materiál získaný týmto spôsobom a jeho použitie - Google Patents

Spôsob prípravy antigénového materiálu obsahujúceho polysacharid a/alebo glykopeptid, materiál získaný týmto spôsobom a jeho použitie Download PDF

Info

Publication number
SK282746B6
SK282746B6 SK177-98A SK17798A SK282746B6 SK 282746 B6 SK282746 B6 SK 282746B6 SK 17798 A SK17798 A SK 17798A SK 282746 B6 SK282746 B6 SK 282746B6
Authority
SK
Slovakia
Prior art keywords
dsm
asmp
anmp
aemp
preparation
Prior art date
Application number
SK177-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK17798A3 (en
Inventor
Dieter Farnov
Joachim Karle
Igor D. Poliakov
Ludmilla G. Ivanova
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of SK17798A3 publication Critical patent/SK17798A3/sk
Publication of SK282746B6 publication Critical patent/SK282746B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/165—Yeast isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/72—Candida
    • C12R2001/725—Candida albicans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/921—Candida
    • Y10S435/922—Candida albicans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SK177-98A 1995-08-11 1996-08-09 Spôsob prípravy antigénového materiálu obsahujúceho polysacharid a/alebo glykopeptid, materiál získaný týmto spôsobom a jeho použitie SK282746B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9516461A GB2304347A (en) 1995-08-11 1995-08-11 Antigenic preparations
PCT/EP1996/003535 WO1997007232A1 (en) 1995-08-11 1996-08-09 Antigenic preparations

Publications (2)

Publication Number Publication Date
SK17798A3 SK17798A3 (en) 1998-07-08
SK282746B6 true SK282746B6 (sk) 2002-12-03

Family

ID=10779086

Family Applications (1)

Application Number Title Priority Date Filing Date
SK177-98A SK282746B6 (sk) 1995-08-11 1996-08-09 Spôsob prípravy antigénového materiálu obsahujúceho polysacharid a/alebo glykopeptid, materiál získaný týmto spôsobom a jeho použitie

Country Status (25)

Country Link
US (2) US6379678B1 (cs)
EP (1) EP0863991B1 (cs)
JP (3) JP4285768B2 (cs)
KR (1) KR100447926B1 (cs)
CN (1) CN1228450C (cs)
AR (1) AR008982A1 (cs)
AT (1) ATE253641T1 (cs)
AU (1) AU717731B2 (cs)
CA (1) CA2229203C (cs)
CO (1) CO4750671A1 (cs)
CZ (1) CZ294394B6 (cs)
DE (1) DE69630611T2 (cs)
DK (1) DK0863991T3 (cs)
ES (1) ES2206588T3 (cs)
GB (1) GB2304347A (cs)
HU (1) HU224223B1 (cs)
IL (1) IL123153A (cs)
MX (1) MX9801180A (cs)
NZ (1) NZ316062A (cs)
PL (1) PL186523B1 (cs)
PT (1) PT863991E (cs)
RU (1) RU2245721C2 (cs)
SK (1) SK282746B6 (cs)
WO (1) WO1997007232A1 (cs)
ZA (1) ZA966801B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
GB2304347A (en) * 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0834322A3 (en) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine
WO1999049876A2 (en) * 1998-03-31 1999-10-07 Abbott Laboratories Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
CA2325063A1 (en) * 2000-10-27 2002-04-27 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Method for detecting antibodies to and antigens of fungal and yeast exposures
RU2217163C2 (ru) * 2002-02-19 2003-11-27 Государственное научное учреждение Саратовская научно-исследовательская ветеринарная станция Вакцина против кандидоза сельскохозяйственных животных
CN102370974B (zh) * 2002-12-16 2014-09-17 全球免疫股份有限公司 用于免疫治疗的基于酵母的疫苗
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
WO2010032139A1 (en) * 2008-09-17 2010-03-25 Hunter Immunology Limited Bacterial and fungal vaccines for the treatment of asthma
RU2660365C1 (ru) * 2015-11-20 2018-07-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) Способ получения специфических антигенных препаратов из клинически значимых дрожжевых грибов
SI3429616T1 (sl) 2016-03-15 2021-12-31 Igor Polyakov Sestavki za zdravljenje in preprečevanje bolezni kopit in krempljev
EP3429600B1 (en) 2016-03-15 2021-03-03 Igor Polyakov New immunobiological products

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867555A (en) * 1972-11-29 1975-02-18 Anheuser Busch Manufacture of yeast protein isolate having a reduced nucleic acid content by an alkali process
GB1541511A (en) * 1976-01-19 1979-03-07 Idemitsu Kosan Co Polysaccharide and process for the production thereof
JPS536413A (en) * 1976-07-07 1978-01-20 Kureha Chem Ind Co Ltd Preparation of n-containing polysaccharides
NO153458C (no) * 1978-06-07 1986-03-26 Inst Experimentalnoi Veterinar Fremgangsm¨te for fremstilling av vaksine for profylakse o g behandling av ringorm hos pelsdyr og kaniner for¨rsaket av trichophyton mentagrophytes.
SU835446A1 (ru) * 1978-06-07 1981-06-07 Всесоюзный Ордена Ленина Институтэкспериментальной Ветеринариивсесоюзной Ордена Ленина Академиисельскохозяйственных Науким. B.И.Ленина Вакцина дл специфической профилактики и лЕчЕНи ТРиХОфиТии пушНыХ зВЕРЕй иКРОлиКОВ-MEHTABAK,СпОСОб изгОТОВлЕНи ВАКциНы и СпОСОб EE иСпОльзОВАНи
AU547928B2 (en) * 1981-11-03 1985-11-14 Sutka, K. Antigenic preparation from candida guilliermondii
GB8506373D0 (en) * 1985-03-12 1985-04-11 Axon Healthcare Ltd Antigens antibodies
GB8913737D0 (en) 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
WO1991015878A1 (de) 1990-04-09 1991-10-17 Adalbert Kopera Antennenanordnung
US5277904A (en) * 1990-10-26 1994-01-11 Pier Allan C Broad spectrum dermatophyte vaccine
RU2020959C1 (ru) 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
RU2020950C1 (ru) * 1993-04-01 1994-10-15 Анна Генадиевна Пономарева Сбор лекарственных растений "вера" для реабилитации организма после орз
WO1995005400A1 (en) 1993-08-19 1995-02-23 Minnesota Mining And Manufacturing Company Heparin functional affinity supports
AUPM473294A0 (en) * 1994-03-25 1994-04-21 Franklyn, Kathleen Mary Peptides for diagnostics and therapeutics
GB2304347A (en) * 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0834322A3 (en) 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine

Also Published As

Publication number Publication date
AU6820796A (en) 1997-03-12
US20040071737A1 (en) 2004-04-15
JP2008245658A (ja) 2008-10-16
KR100447926B1 (ko) 2004-11-09
KR19990036326A (ko) 1999-05-25
DE69630611D1 (de) 2003-12-11
DK0863991T3 (da) 2004-02-09
JP4286312B2 (ja) 2009-06-24
PL186523B1 (pl) 2004-01-30
JPH11511019A (ja) 1999-09-28
JP4286311B2 (ja) 2009-06-24
SK17798A3 (en) 1998-07-08
CZ294394B6 (cs) 2004-12-15
JP2008266352A (ja) 2008-11-06
MX9801180A (es) 1998-04-30
US7090857B2 (en) 2006-08-15
CO4750671A1 (es) 1999-03-31
NZ316062A (en) 1998-12-23
WO1997007232A1 (en) 1997-02-27
IL123153A0 (en) 1998-09-24
CN1228450C (zh) 2005-11-23
PL324975A1 (en) 1998-06-22
AR008982A1 (es) 2000-03-08
CA2229203C (en) 2011-12-13
JP4285768B2 (ja) 2009-06-24
HUP9802419A2 (hu) 1999-02-01
CA2229203A1 (en) 1997-02-27
ES2206588T3 (es) 2004-05-16
AU717731B2 (en) 2000-03-30
ZA966801B (en) 1997-03-14
EP0863991A1 (en) 1998-09-16
HUP9802419A3 (en) 1999-12-28
CZ40098A3 (cs) 1998-07-15
GB9516461D0 (en) 1995-10-11
CN1199426A (zh) 1998-11-18
PT863991E (pt) 2004-01-30
HU224223B1 (hu) 2005-06-28
EP0863991B1 (en) 2003-11-05
IL123153A (en) 2002-05-23
RU2245721C2 (ru) 2005-02-10
ATE253641T1 (de) 2003-11-15
DE69630611T2 (de) 2004-06-03
GB2304347A (en) 1997-03-19
US6379678B1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
JP4286311B2 (ja) 抗原製剤
DE60103066T2 (de) Chlorella zubereitungen mit immunmodulatorischen eigenschaften
RU2687498C2 (ru) Экстракт водорослей для использования в качестве иммуномодулирующего агента
EP0003833B2 (de) Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
AU778953B2 (en) Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
WO2020147570A1 (zh) 赤红球菌产品在治疗白色念珠菌感染引起的疾病中的用途
KR20110036127A (ko) 알레르기 질환 치료를 위한 석곡속 식물 유래 폴리사카라이드 추출물
RU2423139C2 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ Actinidia, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
KR20000029754A (ko) 피부미용조성물용면역조절제로서의올리고당류
JPWO2001095922A1 (ja) アレルギー疾患治療剤およびその製造方法
CN110025636B (zh) 脆弱拟杆菌提取物在制备增强免疫力的组合物中的应用
DE69427653T2 (de) Verbindungen zur verhütung und behandlung von helminthinfektionen
WO2014051296A1 (ko) 청미래덩굴의 뿌리줄기인 토복령 추출물을 함유하는 알러지성 질환을 위한 약학조성물, 화장료 조성물 및 기능성 식품조성물
JP6868060B2 (ja) 皮膚疾患の治療効果を有するキク抽出物の作製方法、皮膚疾患の治療効果を有するキク抽出物、およびその抽出物を含む医薬組成物
EP0342121A2 (en) Anti-allergic extract
Nadaud Effects of a glycopolypeptide from the slime of P. aeruginosa on phagocytosis by mouse macrophages
IE853074L (en) Immunosuppressive agent
WO2024034735A1 (ko) L-ahg를 포함하는 면역 억제용 조성물
KR20180039035A (ko) 피부 가려움증, 짓무름 또는 홍반 증상완화 및 혈액면역인자 회복을 위한 약학 조성물

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20160809